Physician profile
Adrienne Alexandra Brenner
NPI 1588164263
$1,747.67
in general payments reported to CMS, 2019-2025
15 companies · $1,575 in 2025
The $1,575 reported for 2025 was more than what 94% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $173 · 2025: $1,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Travel and Lodging: $813 · Education: $71.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.73 |
| Travel and Lodging | $812.67 |
| Education | $71.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,107.70 | 2025 | Rezum Generator, Ams 700 |
| Mallinckrodt Hospital Products INC. | $101.79 | 2024 | Terlivaz |
| Sumitomo Pharma America, INC. | $79.21 | 2025 | Gemtesa, Orgovyx |
| Veloxis Pharmaceuticals, INC. | $71.27 | 2024 | |
| Olympus America INC. | $58.93 | 2025 | Itind System |
| Abbvie INC. | $50.44 | 2025 | |
| Janssen Biotech, INC. | $50.12 | 2025 | Erleada |
| Immunitybio, INC. | $47.14 | 2025 | |
| Teleflex LLC | $39.61 | 2025 | Barrigel, Urolift |
| Procept Biorobotics Corporation | $30.54 | 2025 | |
| Dendreon Pharmaceuticals LLC | $28.87 | 2025 | Provenge |
| Pfizer INC. | $25.45 | 2025 | |
| Kerecis Limited | $22.75 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Novartis Pharmaceuticals Corporation | $18.00 | 2025 | |
| Progenics Pharmaceuticals, INC. | $15.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrienne Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.